← All organizations
Highest phase reached
Phase 1
First clinical trial
Aug 31, 2024Last known activity
Aug 31, 2024
Timeline
2010s
- Jan 1, 2011
Boston Immune Technologies and Therapeutics— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 1 (1 own, 0 via acquisition)
Recent trials (1)
- NCT06385522Lead sponsorPhase 1Aug 31, 2024
Details
- Founded
- Boston, MA, US Jan 1, 2011
- Last known activity
- Aug 31, 2024